{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:33:38Z","timestamp":1784604818978,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.clcc.2020.03.006","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T11:08:39Z","timestamp":1585739319000},"page":"e129-e136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Disease-Free Survival and Time to Complete Response After Definitive Chemoradiotherapy for Squamous-Cell Carcinoma of the Anus According to HIV Infection"],"prefix":"10.1016","volume":"19","author":[{"given":"Marcos Pedro Guedes","family":"Camandaroba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Iseas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5674-2669","authenticated-orcid":false,"given":"Rodrigo G.","family":"Taboada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana P.","family":"Xerfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine C.","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio S.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Hugo F.","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1055-8118","authenticated-orcid":false,"given":"Tiago","family":"Felismino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Samuel","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Leticia","family":"Gobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso A.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P.","family":"Riechelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2020.03.006_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2036.2009.04026.x","article-title":"Epidermoid anal cancer prognosis comparison among HIV+ and HIV\u2212 patients","volume":"30","author":"Abramowitz","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clcc.2020.03.006_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.soc.2016.07.001","article-title":"Epidemiology of anal canal cancer","volume":"26","author":"Nelson","year":"2017","journal-title":"Surg Oncol Clin North Am"},{"key":"10.1016\/j.clcc.2020.03.006_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"De Martel","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2020.03.006_bib4","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clcc.2020.03.006_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1200\/JCO.2007.14.2810","article-title":"Human immunodeficiency virus\u2013associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era","volume":"26","author":"Chiao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2020.03.006_bib6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0959-8049(00)00009-5","article-title":"Treatment of HIV-associated invasive anal cancer with combined chemoradiation","volume":"36","author":"Cleator","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2020.03.006_bib7","first-page":"34","article-title":"HIV-positive anal cancer: an update for the clinician","volume":"1","author":"Dandapani","year":"2010","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.clcc.2020.03.006_bib8","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L","article-title":"Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal","volume":"51","author":"Nigro","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2020.03.006_bib9","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2020.03.006_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/DCR.0000000000000057","article-title":"Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease","volume":"57","author":"Fraunholz","year":"2014","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2020.03.006_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2010.11.011","article-title":"Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?","volume":"98","author":"Fraunholz","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2020.03.006_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21037\/jgo.2018.10.08","article-title":"Treatment outcomes of patients with localized anal squamous cell carcinoma according to HIV infection: systematic review and meta-analysis","volume":"10","author":"Camandaroba","year":"2019","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.clcc.2020.03.006_bib13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00a0\u00d7 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2020.03.006_bib14","first-page":"1283","article-title":"Clinical presentation and outcome of squamous cell carcinoma of the anus in HIV-infected patients in the HAART-era: a GICAT experience","volume":"16","author":"Martellotta","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.clcc.2020.03.006_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0360-3016(98)00528-8","article-title":"The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer","volume":"44","author":"Hoffman","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2020.03.006_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10350-007-9154-7","article-title":"Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy","volume":"51","author":"Wexler","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2020.03.006_bib17","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1\u2013positive non\u2013small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2020.03.006_bib18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s12094-009-0412-0","article-title":"Treatment of anal carcinoma in immune-compromised patients","volume":"11","author":"Barriger","year":"2009","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.clcc.2020.03.006_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2008.10.046","article-title":"Outcomes of chemoradiotherapy with 5-fluorouracil and mitomycin c for anal cancer in immunocompetent versus immunodeficient patients","volume":"75","author":"Seo","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2020.03.006_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1463-1318.2001.00281.x","article-title":"The efficacy of chemoradiation therapy in HIV seropositive patients with squamous cell carcinoma of the anus","volume":"3","author":"Efron","year":"2001","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.clcc.2020.03.006_bib21","first-page":"413","article-title":"Influence of radiation treatment technique on outcome and toxicity in anal cancer","volume":"6","author":"Fredman","year":"2017","journal-title":"J\u00a0Radiat Oncol"},{"key":"10.1016\/j.clcc.2020.03.006_bib22","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2105\/AJPH.2009.184796","article-title":"Antiretroviral therapy as HIV prevention: status and prospects","volume":"100","author":"Mayer","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/j.clcc.2020.03.006_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/hiv.09.58","article-title":"Role of the CD4 count in HIV management","volume":"4","author":"Hoffman","year":"2010","journal-title":"HIV Ther"},{"key":"10.1016\/j.clcc.2020.03.006_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2844","article-title":"Association of HIV status with outcomes of anal squamous cell carcinoma in the era of highly active antiretroviral therapy","volume":"4","author":"Bryant","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clcc.2020.03.006_bib25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cid\/ciw764","article-title":"HIV infection, immunosuppression, and age at diagnosis of non-AIDS\u2013defining cancers","volume":"64","author":"Shiels","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clcc.2020.03.006_bib26","article-title":"Anal cancer in HIV-positive patients: state of the art","volume":"3","author":"Martellotta","year":"2016","journal-title":"World Cancer Res J"},{"key":"10.1016\/j.clcc.2020.03.006_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003088-200544020-00001","article-title":"Interactions between antiretrovirals and antineoplastic drug therapy","volume":"44","author":"Antoniou","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clcc.2020.03.006_bib28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41591-019-0442-2","article-title":"Molecular profiling in precision medicine oncology","volume":"25","author":"Le Tourneau","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.clcc.2020.03.006_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1200\/EDBK_237433","article-title":"The management and prevention of anal squamous cell carcinoma","volume":"39","author":"Eng","year":"2019","journal-title":"Am Soc Clin Oncol Educ B"},{"key":"10.1016\/j.clcc.2020.03.006_bib30","doi-asserted-by":"crossref","DOI":"10.21037\/tgh.2019.08.02","article-title":"Anal cancer and immunotherapy\u2014are we there yet?","volume":"4","author":"Bian","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2020.03.006_bib31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1470-2045(17)30104-3","article-title":"Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study","volume":"18","author":"Morris","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2020.03.006_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pvr.2017.12.006","article-title":"Therapeutic vaccines for high-risk HPV-associated diseases","volume":"5","author":"Chabeda","year":"2018","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.clcc.2020.03.006_bib33","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1016\/j.vaccine.2009.04.041","article-title":"The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix","volume":"27","author":"Maciag","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.clcc.2020.03.006_bib34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2020.03.006_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bpg.2016.02.009","article-title":"Probiotics, prebiotics and colorectal cancer prevention","volume":"30","author":"Ambalam","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002820300438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002820300438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:07:27Z","timestamp":1761520047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002820300438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1533002820300438"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2020.03.006","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-Free Survival and Time to Complete Response After Definitive Chemoradiotherapy for Squamous-Cell Carcinoma of the Anus According to HIV Infection","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2020.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}